Method and device for treating cardiac arrhythmias

US11717694B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11717694-B2
Application numberUS-202117342405-A
CountryUS
Kind codeB2
Filing dateJun 8, 2021
Priority dateSep 3, 2009
Publication dateAug 8, 2023
Grant dateAug 8, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides both methods and devices for termination of arrhythmias, such as ventricular or atrial tachyarrhythmias. The device and method involves application of alternating current (AC) for clinically significant durations at selected therapeutic frequencies through the cardiac tissue to a subject experiencing arrhythmia. Methods are also provided to minimize or eliminate pain during defibrillation.

First claim

Opening claim text (preview).

What is claimed is: 1. A device comprising: a housing configured to be positioned external to a patient; and a waveform generator configured to generate an alternating current (AC) and an electrical shock, the waveform generator being disposed in the housing and the waveform generator is configured to be connected electrically to at least one electrode configured to be positioned externally on the patient; wherein the electrical shock is at least 400 volts (V), and wherein the AC has a frequency in a range between 50 Hz to 20 kHz, has a duration, and includes a ramped amplitude waveform defined by a gradually increasing peak-to-peak amplitude of the AC during at least sixty percent of the duration. 2. The device of claim 1 , wherein the AC has a frequency between about 50 Hz to 310 Hz. 3. The device of claim 1 , wherein the device is configured to administer the AC after a delay from onset of cardiac excitation. 4. The device of claim 1 , wherein the electrical shock is a biphasic electrical shock following application of the AC. 5. The device of claim 1 , wherein the AC has a frequency between 50 Hz and 500 Hz. 6. The device of claim 1 , wherein the AC has a frequency between 500 Hz and 1 kHz. 7. The device of claim 1 , wherein the AC has a frequency between 250 Hz and 500 Hz. 8. The device of claim 1 , wherein the electrical shock is delivered by the waveform generator immediately after the application of the AC. 9. The device of claim 1 , wherein the peak-to-peak amplitude of the AC increases until the application of the electrical shock. 10. The device of claim 1 , wherein the peak-to-peak amplitude of the AC increases throughout the duration of the AC. 11. The device of claim 1 , wherein the ramped amplitude waveform is a gradually increasing sine wave. 12. The device of claim 1 , wherein the ramped amplitude waveform is a gradually increasing triangular wave. 13. The device of claim 1 , wherein the ramped amplitude waveform is a gradually increasing square wave. 14. The device of claim 1 , wherein the electrical shock is administered after offset of the AC. 15. The device of claim 1 , wherein the electrical shock is administered after onset of the AC and no later than offset of the AC. 16. The device of claim 1 , wherein the duration is in a range of 0.025 to 5 seconds. 17. The device of claim 1 , wherein the duration is in a range of 0.025 to 2.0 seconds. 18. The device of claim 1 , wherein the gradually increasing peak-to-peak amplitude increases for at least seventy percent of the duration of the AC. 19. The device of claim 1 , wherein the electrical shock is a biphasic electrical shock following application of the AC. 20. The device of claim 1 , wherein the frequency between 50 Hz and 20 kHz is a plurality of frequencies between 50 Hz and 20 kHz generated during the duration.

Assignees

Inventors

Classifications

  • A61N1/3962Primary

    in combination with another heart therapy · CPC title

  • for high-frequency therapy · CPC title

  • for treating or preventing abnormally high heart rate · CPC title

  • occurring in the atrium, i.e. atrial tachycardia · CPC title

  • External stimulators · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11717694B2 cover?
The present invention provides both methods and devices for termination of arrhythmias, such as ventricular or atrial tachyarrhythmias. The device and method involves application of alternating current (AC) for clinically significant durations at selected therapeutic frequencies through the cardiac tissue to a subject experiencing arrhythmia. Methods are also provided to minimize or eliminate p…
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification A61N1/3962. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).